Testosterone Therapy (Low-T) Lawsuit Update: Direct Filing Order Entered in MDL 2545
On October 24, 2014, The Honorable Matthew F. Kennelly entered an Order allowing for the filing of federal complaints directly into the testosterone therapy multidistrict litigation (MDL 2545) pending in the United States District Court for the Northern District of Illinois.
Kristine Kraft, a partner at Schlichter, Bogard & Denton, LLP, has been appointed by Judge Kennelly to the Plaintiffs’ Steering Committee. Kraft and other appointed co-counsel will be the leaders in this national litigation involving victims who allege to have been seriously injured while using testosterone replacement therapies.
On January 31, 2014, the United States Food and Drug Administration (FDA) issued a Safety Announcement that it is investigating a potential link between testosterone use and stroke, myocardial infarction (MI), and death, as demonstrated by published studies. The first study that prompted the FDA’s Safety Announcement was published in the Journal of the American Medical Association (JAMA) in November 2013 and suggested that testosterone replacement drugs may increase the risk of heart attack, stroke and death. The second study, published in the online journal PLos ONE on January 29, 2014, concluded that older men, and younger men with pre-existing diagnosed heart disease, have an increased risk of heart attack following initiation of testosterone therapy.
CBS reports that an FDA Advisory Committee was asked to review the risks and benefits of testosterone drugs in light of recent studies suggesting an increased risk of cardiovascular effects and problems for men. The committee voted 20-1 that the product labels of popular testosterone drugs should be revised to clearly indicate that these drugs have not been shown to reverse common aging issues, including muscle loss and libido. Members of the Advisory Committee also unanimously agreed that evidence linking cardiovascular events and blood clots to testosterone drugs is “inconclusive” and drug manufacturers should be required to conduct long-term studies examining the cardiovascular effects.
If you or a loved one have suffered serious injuries after using testosterone therapy drugs, please contact the attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.
The choice of a lawyer is an important decision and should not be based solely on advertisements.